FDA Law Blog: Biosimilars
JULY 10, 2024
Lenz, Principal Medical Device Regulation Expert — FDA’s Center for Devices and Radiological Health (CDRH) recently partnered with the Digital Medicine Society (DiMe) to host a two-day workshop to help advance the use of patient-generated health data (PGHD) to support improved clinical trials, medical device development, and regulatory science.
Putting Patients First Blog
JANUARY 22, 2025
The NHC will also be debuting a new Trusted Messenger campaign focused on the prevention and management of obesity, diabetes, and cardiovascular disease. In between talks, workshops and panel discussions, HLC attendees have plenty of opportunities to take advantage of an invaluable resource: their fellow health care leaders.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Quality Matters
NOVEMBER 11, 2022
FDA) workshop , my fellow panelist and I addressed the latest developments in the identification and control of nitrosamines in pharmaceutical products. Starting in 2018, concerning levels of these impurities were found in commonly prescribed medicines for blood pressure, diabetes, and other conditions. Earlier this year, at a U.S.
pharmaphorum
AUGUST 24, 2020
We believe that stable small molecule therapy will offer both efficacy and durability advantages to the current treatment paradigm for common retinal diseases such as diabetic retinopathy, DR, and neovascular age related macular degeneration, nAMD”. For media queries please contact Jinna Sidhu hsidhu@smi-online.co.uk
pharmacy mentor
SEPTEMBER 16, 2024
Emerging Wearable Technologies Smart Contact Lenses Companies like Google and Apple have been taking steps towards developing smart contact lenses that can monitor glucose levels in tears, providing a non-invasive method for diabetes management. These lenses could potentially monitor other biomarkers in the future.
pharmacy mentor
SEPTEMBER 16, 2024
Emerging Wearable Technologies Smart Contact Lenses Companies like Google and Apple have been taking steps towards developing smart contact lenses that can monitor glucose levels in tears, providing a non-invasive method for diabetes management. These lenses could potentially monitor other biomarkers in the future.
pharmacy mentor
OCTOBER 4, 2024
Expanding Clinical Services Freed from the time constraints of dispensing, pharmacists can broaden the scope of services offered, including: Chronic Disease Management : Offering regular consultations and monitoring for conditions such as diabetes, hypertension, and asthma, leading to better disease control and patient outcomes.
Expert insights. Personalized for you.
59 
Let's personalize your content